Table 3.
Outcomes => |
Referral | Initial counselling session | Total counselling sessions | NRT gum | NRT lozenge | NRT patch | |
---|---|---|---|---|---|---|---|
Incidence Rate Ratio (IRR) | IRR[95% CI] | IRR[95% CI] | IRR[95% CI] | IRR[95% CI] | IRR[95% CI] | IRR[95% CI] | |
Predictors | Baseline (Intercept)# | 0.003 ***[0.003, 0.003] | 0.002 ***[0.002, 0.002] | 0.005 ***[0.005, 0.005] | 0.047 ***[0.046, 0.048] | 0.028 ***[0.027, 0.028] | 0.018 ***[0.018, 0.019] |
Ration of level (Intervention/control) in Baseline# | 0.877 ***[0.813, 0.947] | 1.000[0.904, 1.107] | 1.034[0.975, 1.097] | 2.286 ***[2.206, 2.368] | 1.942 ***[1.856, 2.033] | 2.504 ***[2.383, 2.631] | |
Trend (Slope) in Control Area in baseline period # | 1.012 ***[1.010, 1.013] | 0.996 ***[0.994, 0.998] | 1.002 ***[1.001, 1.004] | 1.110 ***[1.105, 1.114] | 1.157 ***[1.151, 1.163] | 1.225 ***[1.218, 1.231] | |
Trend (Slope) in intervention Area in comparison to control in baseline period# | 1.001[0.997, 1.004] | 0.998[0.993, 1.003] | 0.997 *[0.994, 1.000] | 0.974 ***[0.967, 0.981] | 0.994[0.985, 1.003] | 0.951 ***[0.942, 0.961] | |
Level in Control Area in Period 2 | 0.774 ***[0.737, 0.814] | 1.026[0.950, 1.109] | 1.107 ***[1.062, 1.153] | NA | NA | NA | |
Level in intervention Area in comparison to control area in Period 2 | 1.457 ***[1.305, 1.628] | 1.580 ***[1.335, 1.869] | 1.430 ***[1.305, 1.567] | NA | NA | NA | |
Level in Control Area in Period 3 | 1.115[0.964, 1.289] | 0.731 **[0.577, 0.927] | 0.975[0.869, 1.093] | 3.481 ***[3.406, 3.558] | 5.264 ***[5.127, 5.405] | 3.795 ***[3.678, 3.915] | |
Level in intervention Area in comparison to control area in Period 3 | 3.385 ***[2.575, 4.448] | 3.486 ***[2.282, 5.325] | 3.516 ***[2.849, 4.340] | 1.936 ***[1.865, 2.010] | 2.414 ***[2.302, 2.531] | 2.216 ***[2.102, 2.336] | |
Trend (Slope) in Control Area in Period 3 | 1.002[0.999, 1.004] | 1.011 ***[1.006, 1.015] | 1.008 ***[1.005, 1.010] | 0.905 ***[0.902, 0.909] | 0.871 ***[0.866, 0.875] | 0.820 ***[0.816, 0.825] | |
Trend (Slope) in intervention Area in comparison to control in Period 3 | 0.986 ***[0.981, 0.991] | 0.986 ***[0.979, 0.994] | 0.987 ***[0.983, 0.991] | 1.009 *[1.002, 1.017] | 0.990 *[0.981, 0.999] | 1.026 ***[1.016, 1.036] | |
Model Fit | AIC | 2039.824 | 1573.191 | 2164.507 | 40516.473 | 51705.044 | 7761.862 |
BIC | 2069.241 | 1602.607 | 2193.924 | 40533.990 | 51722.561 | 7779.379 | |
R[2] | 0.918 | 0.866 | 0.946 | 0.693 | 0.692 | 0.819 |
Notes:
*** p < 0.001; ** p < 0.01; * p < 0.05;
Referral:the number of client referrals to the Quitline service received by the Health Contact Centre of Queensland Health (HCC). This could be either by client self-referral or third party referral from another person or organisation.
Participation/ Initial counselling session:the number of clients who completed at least the first Quitline call.
Interaction/ Total counselling sessions: the number of individual Quitline telephone counselling sessions completed in the study area comprising of initial and subsequent calls.
NRT gum dispatch: the number of nicotine gum (4 mg) pieces dispatched to Intensive Quit Support Program (IQSP) clients.
NRT lozenge dispatch: the number of nicotine lozenges (4 mg) dispatched to IQSP clients.
NRT patch dispatch: the number of nicotine patches (21 mg) dispatched to IQSP clients.
Period 1= Pre-launch period of any intervention (Jan-2014 to Jan-2017), N=44 months;Period 2= Time between launching of IQSP by Quitline until the “10,000 Lives” started to work (February 2017 to August 2017), N=07 months;Period 3 = Post-launch period of “10,000 Lives”(November 2017 to December 2019), N=26 months; @Data of this outcome during pre-intervention is only for 7 periods which may cause error in estimation and adjustment of seasonality is not viable. # Baseline period for the outcomes: Referral, initial counselling session and total counselling sessions isPeriod 1and for NRT (gum, lozenge and patch) isPeriod 2.